AI analysis of sounds to spot early signs of heart failure worsening
Tests an AI tool analysing voice, cough and breathing sounds in adults with heart failure.
Key facts
- Who runs it
- Cambridge University Hospitals NHS Foundation Trust
- Where
- Cambridge, United KingdomSee the site
- Trial code
- Registry title
- Utilising AI Analysis of Sounds To prEdict heaRt failurE decOmpensation
- Status
- Recruiting
- People taking part
- 250 people, planned
- Started
- 18 Sept 2024
- Expected to end
- 15 Aug 2027
- Type of study
- Observational
- Treatments tested
- Height, weight, and BMI
- Medical history
- Physical examination
- Venous blood samples
- Resting vital signs
- Transthoracic echocardiogram
- Sound recordings
- Lung ultrasound
- KCCQ questionnaire
- ASCEND-HF score
- Composite Everest congestion score
- Bio impedance and total body water measurement
- Record updated
- 12 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with long-term heart failure, NYHA Class 3 or 4, who have a smartphone to record their voice, cough and breathing sounds for an AI tool.
- Age
- 18 years or older
- Sex
- Men and women
- Disease stage
- Chronic stable heart failure, NYHA Class 3 or 4 (at the latest heart clinic visit, or acute decompensated heart failure during a recent or current hospital stay).
Main reasons for not taking part
- Unable to give consent
- Known pneumonia or significant lung disease (asthma, COPD, pulmonary fibrosis, interstitial lung disease, pulmonary hemorrhage)
- Current pulmonary embolus
- Other acute illness with symptoms at the time of recording, such as a viral or bacterial infection
- Tracheostomy, aphasia, or past head, neck or larynx surgery that affects the vocal cords
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Male or Female, aged 18 years or above
- Diagnosed with chronic stable heart failure NYHA Class 3 or 4 (either during most recent cardiology/heart failure clinic visit, or ADHF during recent/current hospitalization)
- Participant is willing and able to give informed consent for participation in the study
- Participant has a smartphone device and can download a purposely designed mobile application on their phone (with guidance from the study investigators) or is willing to have sound recordings via a smartphone device loaned for the purpose of the study
Who cannot take part
- Patients requiring continuous oxygen therapy at flow rates that cannot be provided through nasal cannula
- Patients requiring continuous oxygen therapy at flow rates that cannot be provided through nasal cannula
- Patients with tracheostomy or who have undergone a surgical procedure to the head/neck/larynx which would affect the normal functioning of the vocal cords
- Patients with known significant pulmonary disease including asthma, COPD, pulmonary fibrosis/interstitial lung disease, pulmonary hemorrhage
- Patients with other intercurrent acute symptomatic illness (e.g., viral/bacterial infection) at time of recording
- Unable to provide consent
- Patients with currently known pneumonia
- Patients with current Pulmonary embolus
- Aphasic
- Patients excluded at PI discretion
Where in United Kingdom
- Cambridge University Hospitals NHS Foundation TrustCambridge, United KingdomContact: Joseph Cheriyan, MBChB MA FRCP FESC FACCTaking people
About the trial
What the trial wants to find out
Heart failure impacts more than 2% of people in the UK (United Kingdom) and leads to about 5% of emergency hospital visits. Patients might have slowly worsening symptoms or suddenly face acute decompensated heart failure (ADHF), marked by intense difficulty in breathing due to fast-developing lung congestion. This is a serious emergency requiring in-hospital treatment and monitoring. Once stable, patients usually have a phase where symptoms remain constant. But as time goes on, those with heart failure often face more frequent and prolonged episodes of ADHF.
Read full original descriptionShow less
Fluid build-up (pulmonary congestion) in the lungs is a key issue in heart failure, and catching it early helps avoid unexpected hospital stays. Spotting these early signs outside the hospital can be tough, as symptoms aren't always clear. Study investigators are working on a new, non-invasive way to identify these early signs using AI (artificial intelligence) to analyse subtle changes in a patient's voice, cough, and breathing sounds. This tool will act as an early warning for patients and their heart care teams, allowing quicker treatment. This could make heart failure episodes less severe and reduce the need for hospital visits.
This research has two parts. First, a small pilot trial with up to 50 patients. The findings will guide and inform a larger study involving up to 200 patients. From this larger study, investigators will develop the final version of the AI algorithm. The results from the Part A and Part B of this research will guide the investigators in planning a future clinical trial. This trial will confirm if the AI algorithm can be effectively used as a medical tool for heart failure care within the NHS (National Health Service). Study investigators will seek the necessary ethical approval before starting this trial.
The group in the trial
- Patients with heart failure
Diagnosed with chronic stable heart failure NYHA Class 3 or 4 (either during most recent cardiology/heart failure clinic visit, or ADHF during recent/current hospitalization).
Treatment: Height, weight, and BMI, Medical history, Physical examination, Venous blood samples, Resting vital signs, Transthoracic echocardiogram, Sound recordings, Lung ultrasound, KCCQ questionnaire, ASCEND-HF score, Composite Everest congestion score, and Bio impedance and total body water measurement
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Utilising AI Analysis of Sounds To prEdict heaRt failurE decOmpensation
- Plain-language title
- AI analysis of sounds to spot early signs of heart failure worseningGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 12 May 2026